Short-term effectiveness of inpatient cancer rehabilitation: A longitudinal controlled cohort study by Ture, Maria et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Short-term effectiveness of inpatient cancer rehabilitation: A longitudinal
controlled cohort study
Ture, Maria; Angst, Felix; Aeschlimann, André; Renner, Christoph; Schnyder, Ulrich; Zerkiebel, Nic;
Perseus, Josef; Barth, Jürgen; Bredell, Marius; Martin-Soelch, Chantal; Walt, Heinrich; Jenewein, Josef
Abstract: Background: Inpatient rehabilitation for cancer patients has been demonstrated to improve
patients’ health related quality of life (HRQoL) effectively. The purpose of this study was to compare
changes in general health and HRQoL of cancer patients who were referred to inpatient rehabilitation (IR)
with those in two control groups who underwent outpatient management either with advice for inpatient
rehabilitation (A+) or without (A-). Methods: In this naturalistic, longitudinal, controlled cohort study,
changes in general health and HRQoL were assessed at either discharge of acute hospital or start of
rehabilitation (baseline) and at the follow-up 3 weeks later or end of rehabilitation. Outcome variables
included general health and HRQoL assessed by the Short Form 36 (SF-36) and the Functional Assessment
of Cancer Therapy (FACT), and fatigue (FACT-F), depression and anxiety by the Hospital Anxiety
and Depression Scale (HADS). Changes on the scores were compared with bivariate and multivariate
analyses using standardized mean differences (SMD). Results: IR patients (n=133) were on average
older, reported lower HRQoL and health, and suffered more frequently from carcinoma than patients
of the A+ (n=30) and the A- (n=82) groups. In the IR patients, pain, physical functioning, mental
health, vitality, and fatigue improved significantly compared to the A+ controls. Compared to the A-
group, the bivariate effects were lower but still statistically significant on many scales. Conclusions: IR
showed moderate, statistically significant superior effects over outpatient management of cancer patients
after acute treatment. Findings indicate that inpatient cancer rehabilitation can be recommended as an
effective management after acute treatment. As today, referrals to inpatient rehabilitation for cancer
patients are still not based on structured standardized procedures, the implementation of such screening
is needed to address patients’ needs and to render the potential for rehabilitation more reliable.
DOI: https://doi.org/10.7150/jca.19564
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-138999
Published Version
 
 
Originally published at:
Ture, Maria; Angst, Felix; Aeschlimann, André; Renner, Christoph; Schnyder, Ulrich; Zerkiebel, Nic;
Perseus, Josef; Barth, Jürgen; Bredell, Marius; Martin-Soelch, Chantal; Walt, Heinrich; Jenewein, Josef
(2017). Short-term effectiveness of inpatient cancer rehabilitation: A longitudinal controlled cohort study.
Journal of Cancer, 8(10):1717-1725.
DOI: https://doi.org/10.7150/jca.19564
2
Journal of Cancer 2017, Vol. 8 
 
 
http://www.jcancer.org 
1717 
Journal of Cancer 
2017; 8(10): 1717-1725. doi: 10.7150/jca.19564 
Research Paper 
Short-term effectiveness of inpatient cancer 
rehabilitation: A longitudinal controlled cohort study 
Maria Ture1, Felix Angst2, André Aeschlimann2, Christoph Renner3, Ulrich Schnyder4, Nic Zerkiebel5, Josef 
Perseus6, Jürgen Barth7, Marius Bredell1, Chantal Martin Soelch8, Heinrich Walt1, Josef Jenewein4 
 Department of Cranio-, Maxillo-Facial and Oral Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland 
 RehaClinic Bad Zurzach, Zurzach, Switzerland 
 Oncology Centre Hirslanden Zurich, Switzerland 
 Department of Psychiatry and Psychotherapy, University Hospital Zurich, University of Zurich, Switzerland 
 Susenberg Klinik Zurich, Switzerland 
 Zürcher RehaZentrum Davos, Switzerland 
 Institute of Complementary and Integrative Medicine, University Hospital Zurich, University of Zurich, Switzerland 
 Department of Psychology, Unit of Clinical and Health Psychology, University of Fribourg, Switzerland  
 Corresponding author: Josef Jenewein, MD, Department of Psychiatry and Psychotherapy, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, 
Switzerland. Phone: +41 44 255-5257, Fax: +41 44 255-9701, Email address: josef.jenewein@usz.ch 
© Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license 
(https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. 
Received: 2017.02.08; Accepted: 2017.05.02; Published: 2017.07.01 
Abstract 
Background: Inpatient rehabilitation for cancer patients has been demonstrated to improve patients’ 
health related quality of life (HRQoL) effectively. The purpose of this study was to compare changes in 
general health and HRQoL of cancer patients who were referred to inpatient rehabilitation (IR) with 
those in two control groups who underwent outpatient management either with advice for inpatient 
rehabilitation (A+) or without (A-).  
Methods: In this naturalistic, longitudinal, controlled cohort study, changes in general health and 
HRQoL were assessed at either discharge of acute hospital or start of rehabilitation (baseline) and at 
the follow-up 3 weeks later or end of rehabilitation. Outcome variables included general health and 
HRQoL assessed by the Short Form 36 (SF-36) and the Functional Assessment of Cancer Therapy 
(FACT), and fatigue (FACT-F), depression and anxiety by the Hospital Anxiety and Depression Scale 
(HADS). Changes on the scores were compared with bivariate and multivariate analyses using 
standardized mean differences (SMD). 
Results: IR patients (n=133) were on average older, reported lower HRQoL and health, and suffered 
more frequently from carcinoma than patients of the A+ (n=30) and the A- (n=82) groups. In the IR 
patients, pain, physical functioning, mental health, vitality, and fatigue improved significantly compared to 
the A+ controls. Compared to the A- group, the bivariate effects were lower but still statistically 
significant on many scales.  
Conclusions: IR showed moderate, statistically significant superior effects over outpatient 
management of cancer patients after acute treatment. Findings indicate that inpatient cancer 
rehabilitation can be recommended as an effective management after acute treatment. As today, 
referrals to inpatient rehabilitation for cancer patients are still not based on structured standardized 
procedures, the implementation of such screening is needed to address patients’ needs and to render 
the potential for rehabilitation more reliable. 
Key words: Rehabilitation; Inpatient rehabilitation; Cancer; Effectiveness; Quality of Life; Health; Fatigue; 
Anxiety; Depression. 
Background 
Cancer and cancer therapies, such as surgery, 
radiotherapy, and chemotherapy, significantly affect 
physical and psychological health as well as HRQoL 
[1]. Physical side effects such as functional loss, 
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muscle weakness, and fatigue frequently lead to 
substantial limitations in patients’ daily activities [2].  
Rehabilitation aims to enable individuals to 
achieve optimal levels of physical, functional, 
psychosocial and vocational functioning [3,4]. 
Further, it helps to maintain social integration and 
participation in everyday life [5]. Because of the 
variety of problems cancer patients may face, 
inpatient rehabilitation programs offer 
comprehensive multidisciplinary care. Current 
research shows that rehabilitation improves HRQoL 
and physical as well as psychological health in cancer 
patients [1,6,7]. In Switzerland, inpatient 
rehabilitation usually lasts about three weeks [8,9], 
and consists mainly of physical therapy and other 
treatments (e.g. nutrition counseling, lymphatic 
drainage, psychotherapy) [10]. 
Most studies of cancer rehabilitation have 
focused on specific interventions, such as exercise 
programs designed in outpatient settings [11–13]. 
Some studies have found that inpatient rehabilitation 
programs had beneficial effects on health and HRQoL 
[14–18]. However, most of these studies used a 
pre-post design without control groups. In 
multidisciplinary rehabilitation programs without 
control groups, moderate to large effect sizes have 
been observed in social functioning, vitality, role 
functioning, and health [1,19]. Weis and collaborators 
found more pronounced improvements in HRQoL for 
the rehabilitation group than for the control group, 
partly due to the poorer baseline values of the 
intervention group [20].  
Rehabilitation for cancer patients is not well 
established in Switzerland [4,14]. Despite comparable 
levels of impairments, cancer patients are less likely to 
use rehabilitation than patients suffering from other 
chronic diseases [21–24]. Lack of identification of 
patients’ need for rehabilitation, lack of information, 
and lack of financial support have been identified as 
major barriers to optimal delivery of rehabilitation 
care [25].  
To our best knowledge, there are currently no 
empirical data about the effectiveness of inpatient 
rehabilitation for cancer patients in Switzerland. The 
main aim of this study was therefore to compare 
changes in the general health and HRQoL of cancer 
patients who underwent inpatient rehabilitation (IR) 
with those in control groups of patients with (A+) and 
without (A-) medical advice for inpatient 
rehabilitation (outpatient management). We 
hypothesized that inpatient rehabilitation would lead 
to greater improvements in general health and 
HRQoL than outpatient management at home. 
Methods  
Participants 
A total of 476 patients who underwent acute 
treatment for cancer in two hospitals and three 
rehabilitation clinics in Switzerland between April 
2013 and November 2014 were asked to participate in 
the study. To be eligible, patients had to be 18 years or 
older. Sufficient German knowledge was required to 
complete the self-report questionnaires, and all 
patients aged over 50 years were screened by the 
German version of the MMSE 
(Mini Mental State 
Examination) and excluded if 
they had a score below 25 
points [26] to ensure 
sufficient cognitive ability to 
complete the questionnaires. 
A total of 101 (21%) patients 
refused to participate. In 
addition, 90 (19%) patients 
were not included due to 
severe cognitive or physical 
impairment or insufficient 
German language skills 
(Figure 1).  
Of the 285 subjects 
included, 40 (14%) dropped 
out between baseline and 
follow-up despite reminder 
calls (28 of the IR, 2 of the A+, 
and 10 of the A- group). 
Reasons for dropout were 
 
Figure 1. Flow chart of enrolled patients in the study. 
 Journal of Cancer 2017, Vol. 8 
 
http://www.jcancer.org 
1719 
severe deterioration of health status, re-admission to 
acute hospital during inpatient rehabilitation 
(premature end of rehabilitation), death, refusal to 
participate, and incomplete data. Thirteen A+ patients 
(43%) did not utilize inpatient rehabilitation because 
they had to wait too long for rehabilitation, while 17 
(57%) did not receive reimbursement of costs from 
their health insurance companies. Complete data at 
baseline (T0) and follow-up (T1) of a total of 245 
patients were obtained for analysis: IR (n=133), A+ 
(n=30), and A- (n=82). 
Study design 
This multicenter, naturalistic, longitudinal, 
controlled cohort study grouped participants 
according to the following types of setting after 
hospital discharge: a) subjects with referral to 
rehabilitation who used inpatient rehabilitation (IR); 
b) subjects with medical advice for inpatient 
rehabilitation but without reimbursement of costs or 
subjects who were discharged home from the acute 
hospital as the waiting time for an available place in 
the rehabilitation clinic was too long (home with 
advice, A+); and c) subjects without medical advice for 
inpatient rehabilitation (home without advice, A-). 
Written informed consent was obtained from all 
participants. The study was approved by the Ethical 
Committee of the Canton of Zurich (KEK-ZH- Nr. 
2012-0563). 
Procedures 
All participants completed the self-report 
questionnaires either at discharge from hospital or at 
the first day of inpatient rehabilitation for those 
patients who were referred from other hospitals to 
inpatient rehabilitation (baseline, T0) and three weeks 
later either at home (control groups) or at the end of 
rehabilitation (follow-up, T1). Pre- and postoperative 
treatments and the need for inpatient rehabilitation 
depended on the case by case decision of the doctors 
of the acute hospitals. Referrals to inpatient 
rehabilitation were organized as usual by the social 
services of hospitals. We did not influence either the 
referral procedure or the treatment procedure so as to 
avoid biasing current clinical practice (naturalistic 
design).  
Intervention 
Post-acute hospital inpatient rehabilitation for 
cancer patients can include comprehensive 
management. No standardized cancer-specific 
rehabilitation programs were applied. The use and 
intensity of treatments were tailored to each 
individual depending on the severity of impairment, 
which was assessed at the beginning of rehabilitation. 
Inpatient rehabilitation includes three to four different 
treatment components (e.g. physical therapy, 
nutrition counselling, lymphatic drainage, 
swallowing therapy, psychotherapy) according to 
medical prescription. Inpatient rehabilitation can be 
reimbursed by health insurance companies for two to 
three weeks. In the A+ and A- group, patients received 
outpatient treatment such as physical therapy, 
nutrition counselling, and psychotherapy if medically 
prescribed.  
Measures 
Sociodemographic data (gender, age, 
nationality) and disease-relevant data (insurance type, 
cancer site, cancer type, treatment, comorbidities) 
were taken from the patients’ clinical records (Table 
1). Additional sociodemographic information such as 
employment status, highest attained education, living 
status, minor children in household, income, 
smoking, alcohol consumption and interventions after 
hospital stay were obtained by standardized 
questionnaires (Table 1). Tumor stage was classified 
according to the Tumor-Node-Metastasis (TNM) 
Classification of Malignant Tumors, except for brain 
and hematological malignancies [27]. 
Comprehensive physical, mental, and 
psycho-social health parameters were assessed using 
the generic Short-Form (SF-36) Health Survey [44,28]. 
The SF-36 comprises 12 subscales: physical 
functioning, role physical, bodily pain, general health, 
vitality, social functioning, role emotional 
functioning, mental health, physical component 
summary (PCS), and mental component summary 
(MCS). 
HRQoL was assessed by the disease-specific 
Functional Assessment of Cancer Therapy General 
Scale, version 4 (FACT) [29]. The FACT measures the 
functional, social, emotional, and physical domains of 
HRQoL (Tables 2 and 3). Fatigue was assessed by the 
13-item Fatigue subscale of the FACT measurement 
system, scaled from 0 = maximal fatigue to 52 = no 
fatigue (FACT-F) [30].  
The validated German version of the Hospital 
Anxiety and Depression Scale (HADS) was used to 
assess anxiety and depression [31,32]. The total score 
of each scale ranges from 0 (no anxiety/ depression) to 21 
(maximal anxiety/ depression).  
Statistics 
Baseline characteristics were compared using the 
Mann-Whitney U-test for quasi-continuous data and 
the χ2 test for categorical frequency data. Changes on 
the scales between baseline and follow-up were firstly 
expressed by standardized mean differences 
(bivariate SMD). The SMD represents the difference of 
the mean score differences (baseline to follow-up) 
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between the intervention group (IR) and the control 
groups (A+, A-) divided by the pooled standard 
deviation of the two groups in each comparison [33]. 
Intervals for 95% confidence (95%-CI) were calculated 
for the SMD and t-test based type I errors (p) for 
testing SMD > 0.00 (zero outside the 95%-CI) (Tables 2 
and 3). As a rule, an SMD 0.20-0.49 is considered small 
for effect sizes, 0.50-0.79 moderate, and ≥ 0.80 large 
[34]. 
 
Table 1. Patient’s sociodemographic and medical characteristics at baseline 
Characteristics Inpatient 
rehabilitation (IR) 
n=133 (54.3%) 
Control with 
Advice  
(A+) n=30 (12.2%) 
Control - 
No advice 
(A-) n=82 (33.5%) 
p 
IR vs. A+ 
p  
IR vs. A- 
p  
A+ vs.  
A- 
Age in years (M /IQR) a 62.0 (+/- 14.0) 57.5 (+/- 19.0) 59.0 (+/- 19.0) 0.020 0.012 0.610 
Hospital stay in days (M /IQR) b 18.0 (+/- 9.0) 18.5 (+/- 12.0) 8.5 (+/- 8.0) 0.709 <0.001 <0.001 
Sex (%)       
Male 78 (59%) 19 (63%) 36 (44%) 0.637 0.035 0.069 
Living (%)       
Alone 42 (32%) 8 (27%) 17 (21%) 0.598 0.083 0.504 
Children in household (%)       
Yes 18 (14%) 6 (20%) 13 (16%) 0.367 0.638 0.605 
Level of education (%)    0.372 0.816 0.698 
Basic school (8-9 years) 9 (7%) 4 (13%) 8 (10%)    
Vocational training 68 (51%) 15 (50%) 39 (48%)    
College/high school 22 (17%) 2 (7%) 12 (15%)    
University 34 (26%) 9 (30%) 23 (28%)    
Employment status       
Employed 46 (35%) 16 (53%) 47 (57%) 0.056 0.001 0.707 
Insurance type (%)       
Basic 76 (57%) 25 (83%) 63 (77%) 0.008 0.003 0.458 
Comorbidities (%)    0.423 0.001 0.647 
None 43 (32%) 14 (47%) 49 (60%)    
1 43 (32%) 8 (27%) 17 (21%)    
2 28 (21%) 6 (20%) 11 (13%)    
>2 19 (14%) 2 (7%) 5 (6%)    
Tumor stage (%)    0.994 0.001 0.065 
I 11 (10%) 2 (9%) 17 (25%)    
II 27 (24%) 6 (26%) 18 (27%)    
III 26 (23%) 5 (22%) 20 (30%)    
IV 51 (44%) 10 (44%) 12 (18%)    
Cancer site (%)    0.063 <0.001 <0.001 
Digestive organs 49 (37%) 6 (20%) 4 (5%)    
Thoracic organs 20 (15%) 2 (7%) 5 (6%)    
Head and neck 22 (17%) 13 (43%) 13 (16%)    
Hematological malignancies 15 (11%) 7 (23%) 7 (9%)    
Female genital organs 7 (5%) 1 (3%) 11 (13%)    
Sarcoma 5 (4%) 0 (0%) 15 (18%)    
Breast 8 (6%) 0 (0%) 16 (20%)    
Others 7 (5%) 1 (3%) 11 (13%)    
Cancer type (%)    0.582 0.010 0.026 
Carcinoma 101 (76%) 21 (70%) 50 (61%)    
Sarcoma 10 (8%) 1 (3%) 15(18%)    
Myeloma 8 (6%) 3 (10%) 4 (5%)    
Lymphoma 7 (5%) 4 (13%) 3 (4%)    
Mesothelioma 3 (2%) 1 (3%) 0    
Brain tumor 3 (2%) 0 (0%) 8 (20%)    
Others 1 (1%) 0 (0%) 2 (2%)    
Treatment type (%) d    0.179 0008 0.597 
Surgery 102 (77%) 25 (83%) 74 (90%)    
Stem cell transplantation 6 (5%) 3 (10%) 5 (6%)    
Other 24 (18%) 2 (7%) 3 (4%)    
Physical therapy       
Yes 130 (98%) 15 (50%) 34 (42%) <0.001 <0.001 0.420 
Nutrition counselling       
Yes 78 (59%) 11 (37%) 10 (12%) 0.029 <0.001 0.003 
Psychological therapy       
Yes 42 (32%) 2 (7%) 6 (7%) 0.005 <0.001 1.000 
N=245. a M /IQR: Median /interquartile range. b missing (n=53 only IG). c missing (n=48). d missing (n=1).  
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Table 2. Comparison of inpatient rehabilitation (IR) with control group with advice (A+), from T0 to T1 
 IR (n=133) A+ (n=30)  Bivariate Multivariate 
Scales T0 T1 ∆ T0 T1 ∆ SMD 95%-CI p SMD 95%-CI p R2 
SF-36 Physical functioning 36.6 
(24.2) 
59.4 
(23.6) 
22.7 
(24.2) 
49.5 
(25.1) 
57.8 
(24.8) 
8.3 
(15.8) 
0.62 0.22–1.02 0.001 0.62 0.22–1.02 0.002 37.0 
SF-36 Role physical 22.4 
(21.7) 
43.1 
(23.1) 
20.7 
(22.6) 
29.2 
(25.9) 
39.1 
(24.7) 
9.9 
(23.7) 
0.47 0.08–0.87 0.016 0.46 0.06–0.86 0.023 31.1 
SF-36 Bodily pain 48.4 
(30.6) 
65.0 
(25.9) 
16.6 
(27.4) 
56.5 
(30.0) 
60.0 
(24.7) 
3.5 
(27.1) 
0.48 0.08–0.87 0.015 0.37 -0.02–0.77 0.064 36.9 
SF-36 General health 51.0 
(19.1) 
56.6 
(18.8) 
5.6 
(16.3) 
56.2 
(21.8) 
53.9 
(16.1) 
-2.2 
(14.3) 
0.49 0.09–0.89 0.012 0.40 0.00–0.80 0.047 27.9 
SF-36 Vitality 36.9 
(21.3) 
52.4 
(21.7) 
15.5 
(20.7) 
42.0 
(25.5) 
45.1 
(20.9) 
3.0 
(13.2) 
0.64 0.23–1.04 0.001 0.64 0.24–1.04 0.002 39.9 
SF-36 Social functioning 58.0 
(33.5) 
73.6 
(28.6) 
15.6 
(36.2) 
61.0 
(34.7) 
57.7 
(28.3) 
-3.3 
(30.6) 
0.53 0.14–0.93 0.006 0.70 0.30–1.10 0.001 52.5 
SF-36 Role emotional 50.9 
(33.6) 
64.5 
(29.5) 
13.6 
(34.4) 
55.6 
(33.4) 
62.6 
(31.4) 
7.0 
(31.4) 
0.19 -0.20–0.59 0.332 0.21 -0.18–0.61 0.296 44.0 
SF-36 Mental Health 65.5 
(19.7) 
73.5 
(18.3) 
8.0 
(18.2) 
63.7 
(20.5) 
65.3 
(17.5) 
1.7 
(14.8) 
0.36 -0.04–0.75 0.070 0.46 0.06–0.86 0.023 31.7 
SF-36 PCS 32.2 
(8.0) 
40.0 
(8.0) 
7.8 
(7.9) 
37.0 
(9.3) 
39.3 
(7.5) 
2.3 
(7.0) 
0.71 0.31–1.11 <0.001 0.59 0.20–0.99 0.003 34.2 
SF-36 MCS 42.9 
(12.6) 
47.6 
(11.9) 
4.7 
(12.3) 
42.4 
(13.2) 
42.8 
(11.8) 
0.4 
(10.0) 
0.35 -0.04–0.75 0.073 0.46 0.06–0.86 0.025 38.7 
FACT Physical 15.9 
(6.1) 
20.3 
(5.1) 
4.5 
(5.5) 
17.6 
(6.4) 
18.8 
(5.6) 
1.2 
(4.7) 
0.61 0.21–1.01 0.002 0.51 0.11–0.91 0.012 40.6 
FACT Social 24.3 
(3.8) 
24.1 
(3.7) 
-0.1 
(2.8) 
22.1 
(5.6) 
22.2 
(5.9) 
0.1 
(2.9) 
-0.08 -0.47–0.32 0.695 0.01 -0.38–0.41 0.953 18.5 
FACT Emotional 18.7 
(4.3) 
19.7 
(4.0) 
0.9 
(3.2) 
18.6 
(4.1) 
18.8 
(3.6) 
0.2 
(3.4) 
0.22 -0.17–0.62 0.270 0.19 -0.20–0.58 0.346 25.2 
FACT Functional 12.9 
(6.3) 
16.4 
(6.1) 
3.6 
(6.0) 
13.4 
(5.9) 
14.5 
(5.9) 
1.1 
(4.9) 
0.42 0.03–0.82 0.032 0.42 0.02–0.82 0.039 24.2 
FACT Total 71.7 
(15.0) 
80.6 
(15.1) 
8.8 
(13.1) 
71.8 
(15.4) 
74.3 
(14.4) 
2.6 
(11.3) 
0.49 0.09–0.88 0.013 0.48 0.09–0.88 0.017 23.2 
FACIT Fatigue  25.1 
(12.1) 
34.3 
(11.5) 
9.2 
(11.3) 
29.2 
(13.6) 
31.6 
(11.6) 
2.4 
(10.4) 
0.61 0.21–1.01 0.002 0.54 0.14–0.94 0.008 37.3 
HADS Anxiety 4.8 
(3.2) 
4.0 
(3.3) 
-0.8 
(3.2) 
4.9 
(2.6) 
5.0 
(3.0) 
0.1 
(2.8) 
0.28 -0.11–0.68 0.154 0.37 -0.03–0.76 0.070 24.3 
HADS Depression 6.8 
(4.6) 
5.2 
(4.5) 
-1.6 
(3.6) 
6.0 
(3.8) 
6.6 
(4.2) 
0.6 
(3.2) 
0.62 0.22–1.02 0.001 0.53 0.13–0.93 0.009 20.9 
Legend: All values are arithmetic means, standard deviation in parentheses. SF-36= Short Form Health Short-Form Health Survey Index ranging from 0 = low health to 100 = 
maximal health, FACT-G = Functional Assessment of Cancer Therapy from 0 = low HRQoL to 108 = maximal HRQoL, FACIT-F = Functional Assessment Cancer Therapy 
Fatigue from 0 = maximal Fatigue to 52 = low Fatigue, HADS = Hospital Anxiety Depression Scale from 0 = no anxiety / depression to 21 = maximal anxiety / depression, n 
= number of complete data sets, T0 = hospital discharge / beginning of rehabilitation, ∆ = difference (T1-T0). R2 = Explained variance 
 
Table 3. Comparison of inpatient rehabilitation (IR) with control group – no advice (A-), from T0 to T1 
 IR (n=133) A- (n=82) Bivariate Multivariate 
Scales T0 T1 ∆ T0 T1 ∆ SMD 95%-CI p SMD 95%-CI p R2 
SF-36 Physical functioning 36.6 
(24.2) 
59.4 
(23.6) 
22.7 
(24.2) 
51.0 
(25.4) 
67.2 
(20.4) 
16.2 
(21.2) 
0.28 0.01–0.56 0.040 -0.06 -0.33–0.22 0.674 37.0 
SF-36 Role physical 22.4 
(21.7) 
43.1 
(23.1) 
20.7 
(22.6) 
34.8 
(24.0) 
45.1 
(22.4) 
10.3 
(22.0) 
0.46 0.19–0.74 0.001 0.20 -0.08–0.47 0.160 31.1 
SF-36 Bodily pain 48.4 
(30.6) 
65.0 
(25.9) 
16.6 
(27.4) 
50.9 
(26.8) 
64.8 
(26.9) 
13.9 
(25.9) 
0.10 -0.17–0.37 0.475 0.06 -0.22–0.33 0.683 36.9 
SF-36 General health 51.0 
(19.1) 
56.6 
(18.8) 
5.6 
(16.3) 
62.7 
(17.8) 
62.0 
(18.7) 
-0.7 
(15.2) 
0.40 0.12–0.67 0.003 0.07 -0.21–0.34 0.633 27.9 
SF-36 Vitality 36.9 
(21.3) 
52.4 
(21.7) 
15.5 
(20.7) 
49.4 
(23.9) 
54.2 
(19.3) 
4.7 
(19.0) 
0.54 0.26–0.81 <0.001 0.28 0.00–0.55 0.047 39.3 
SF-36 Social functioning 58.0 
(33.5) 
73.6 
(28.6) 
15.6 
(36.2) 
67.4 
(31.9) 
71.5 
(25.0) 
4.1 
(30.6) 
0.33 0.06–0.61 0.014 0.10 -0.17–0.38 0.458 52.5 
SF-36 Role emotional 50.9 
(33.6) 
64.5 
(29.5) 
13.6 
(34.4) 
64.5 
(30.6) 
67.9 
(28.3) 
3.4 
(36.4) 
0.29 0.01–0.57 0.034 0.03 -0.24–0.31 0.824 44.0 
SF-36 Mental Health 65.5 
(19.7) 
73.5 
(18.3) 
8.0 
(18.2) 
68.7 
(19.6) 
72.0 
(20.1) 
3.3 
(15.6) 
0.27 0.00–0.55 0.046 0.07 -0.20–0.35 0.601 31.7 
SF-36 PCS 32.2 
(8.0) 
40.0 
(8.0) 
7.8 
(7.9) 
36.7 
(8.4) 
42.2 
(7.8) 
5.4 
(7.0) 
0.31 0.03–0.58 0.025 0.05 -0.23–0.32 0.734 34.2 
SF-36 MCS 42.9 
(12.6) 
47.6 
(11.9) 
4.7 
(12.3) 
46.9 
(12.1) 
46.9 
(12.4) 
0.0 
(12.1) 
0.38 0.10–0.66 0.005 0.16 -0.11–0.44 0.241 38.7 
FACT Physical 15.9 
(6.1) 
20.3 
(5.1) 
4.5 
(5.5) 
18.6 
(5.5) 
20.8 
(5.1) 
2.1 
(5.4) 
0.43 0.15–0.70 0.002 0.13 -0.14–0.41 0.346 40.6 
FACT Social 24.3 
(3.8) 
24.1 
(3.7) 
-0.1 
(2.8) 
24.2 
(3.5) 
24.0 
(3.5) 
-0.2 
(2.9) 
0.02 -0.25–0.30 0.876 0.02 -0.25–0.30 0.880 18.5 
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FACT Emotional 18.7 
(4.3) 
19.7 
(4.0) 
0.9 
(3.2) 
19.7 
(3.8) 
19.8 
(3.6) 
0.1 
(2.7) 
0.26 -0.02–0.54 0.058 0.09 -0.19–0.36 0.536 25.2 
FACT Functional 12.9 
(6.3) 
16.4 
(6.1) 
3.6 
(6.0) 
16.0 
(5.7) 
17.7 
(6.1) 
1.8 
(4.1) 
0.33 0.06–0.61 0.015 0.11 -0.16–0.39 0.420 24.2 
FACT Total 71.7 
(15.0) 
80.6 
(15.1) 
8.8 
(13.1) 
78.4 
(14.5) 
82.3 
(15.1) 
3.9 
(10.8) 
0.40 0.13–0.68 0.003 0.20 -0.07–0.48 0.150 23.2 
FACIT Fatigue  25.1 
(12.1) 
34.3 
(11.5) 
9.2 
(11.3) 
33.2 
(11.4) 
35.5 
(10.1) 
2.2 
(8.9) 
0.66 0.38–0.94 <0.001 0.29 0.01–0.56 0.042 37.3 
HADS Anxiety 4.8 
(3.2) 
4.0 
(3.3) 
-0.8 
(3.2) 
4.9 
(3.6) 
4.5 
(3.5) 
-0.4 
(2.3) 
0.14 -0.13–0.42 0.308 0.07 -0.20–0.35 0.601 24.3 
HADS Depression 6.8 
(4.6) 
5.2 
(4.5) 
-1.6 
(3.6) 
4.9 
(3.6) 
4.6 
(4.1) 
-0.3 
(2.9) 
0.37 0.10–0.65 0.006 0.15 -0.13–0.42 0.294 20.9 
Legend: All values are arithmetic mean, standard deviation in parentheses. SF-36= Short Form Health Short-Form Health Survey Index ranging from 0 = low health to 100 = 
maximal health, FACT-G = Functional Assessment of Cancer Therapy from 0 = low HRQoL to 108 = maximal HRQoL, FACIT-F = Functional Assessment Cancer Therapy 
Fatigue from 0 = maximal Fatigue to 52 = low Fatigue, HADS = Hospital Anxiety Depression Scale from 0 = no anxiety / depression to 21 = maximal anxiety / depression, n 
= number of complete data sets, T0 = hospital discharge / beginning of rehabilitation, ∆ = difference (T1-T0), R2 = Explained variance 
 
 
For each score, multivariate SMDs were then 
obtained using the individual score differences 
(baseline to follow-up) as dependent variable for 
stepwise multivariate linear regression modeling. The 
multivariate SMDs were controlled for differences 
between the intervention and control groups to 
identify potential confounders (independent 
variables), namely the different baseline scores of the 
scales under examination, gender, age, number of 
comorbidities, and cancer site. 
The corresponding dependent variable at 
baseline, the grouping variable for A+ (1 for A+, 0 
otherwise), and the grouping variable for A- (1 for A-, 
0 otherwise), were included in the multivariate 
analysis. By so doing, the regression coefficients of the 
grouping variables equaled the differences between 
modelled mean score differences (baseline to 
follow-up) between intervention and control. These 
raw, mean score differences were then used to 
compute SMDs [33]. The pooled standard deviations 
for the SMDs were determined by the standard errors 
of the raw differences obtained by the regression 
models. All statistical analyses were performed using 
the Statistical Package for the Social Sciences (SPSS) 
version 21.0 for Windows (SPSS Inc., Chicago, IL, 
USA). 
Results  
Participants 
Sociodemographic data and disease-relevant 
characteristics are presented in Table 1. Compared to 
both control groups at T0, the IR patients were more 
likely to be older and less often employed, and had 
semi-private/private insurance more often. The IR 
and the A+ stayed longer in hospital, had higher 
tumor stage, and suffered more frequently from 
carcinoma. In addition, the IR had more comorbidities 
and received more interventions during follow-up. 
Patients who underwent surgery were more likely to 
be discharged home. Patients with cancer of digestive 
organs or head and neck were more likely to be 
referred to inpatient rehabilitation, whereas patients 
with breast cancer or cancer of female genital organs 
were less likely to be referred. There were no 
significant differences between the three groups 
regarding living status, minor children in household, 
education level, income, smoking, or risk drinking.  
Effects of inpatient rehabilitation compared to 
subjects with advice for inpatient 
rehabilitation  
Compared to the A+ (n = 30), the IR patients (n = 
133) showed significant improvements with regard to 
SF-36 bodily pain (SMD=0.48 (bivariate)/0.37 
(multivariate)), SF-36 physical functioning 
(SMD=0.62/0.62), SF-36 physical component 
summary (SMD=0.71/0.59), SF-36 vitality 
(SMD=0.64/0.64), and SF-36 mental health 
(SMD=0.36/0.46). The FACT test showed significant 
improvements in the physical (SMD=0.61/0.51) and 
functional (SMD= 0.42/0.42) dimensions, the FACT 
total score (SMD=0.49/0.48), and fatigue 
(SMD=0.61/0.54). IR patients also showed a 
significant improvement regarding HADS depression 
(SMD=0.62/0.43) (Table 2). In total, of the 18 health 
dimensions, 7 bivariate SMDs and 4 multivariate 
SMDs were ≥ 0.50, and 12 bivariate and 11 
multivariate effects were statistically significant at an 
alpha level p < 0.05. No significant multivariate effects 
were found in emotional role (SF-36) or in FACT 
social and emotional dimensions. 
At baseline, SF-36 physical functioning (means: 
36.6 versus 49.5, p=0.008) and SF-36 PCS (means: 32.2 
versus 37.0, p=0.014) were significantly poorer in the 
IR group than in the A+ group. In addition, social 
support was significantly higher in the IR (means 24.3 
versus 22.1, p=0.013). However, controlling for these 
baseline differences by multivariate regression 
modeling did not reduce the multivariate SMDs by 
large amounts when compared to the bivariate, for 
instance, SMDs of SF-36 physical functioning: 0.62 
versus 0.62. The overall fit of the models in predicting 
the effect differences with the confounders ranged 
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from 18.5% (FACT social) to 52.5% (SF-36 social 
functioning). 
Effects of inpatient rehabilitation compared to 
subjects without advice for inpatient 
rehabilitation  
IR patients (n = 133) had higher improvements 
than the A- (n = 82) regarding SF-36 vitality 
(SMD=0.54 (bivariate)/0.28 (multivariate)), SF-36 
physical functioning (SMD=0.31/0.05), SF-36 mental 
health (SMD=0.38/0.16), FACT physical 
(SMD=0.43/0.13), FACT functional (SMD= 0.33/0.11), 
FACT total (SMD=0.40/0.20), FACT fatigue 
(SMD=0.66/0.29), and HADS depression 
(SMD=0.37/0.15) (Table 3). Of the 18 health 
dimensions, 2 bivariate SMDs were ≥0.50, 14 bivariate 
and 1 multivariate effects were statistically significant 
at type I error level p<0.050.  
At baseline, function (all scales of SF-36 except 
bodily pain and FACT), mental health (SF-36, HADS 
depression), and fatigue were significantly poorer in 
the IR group than in the A- group (p<0.001 to 
p=0.044). For example, SF-36 physical functioning 
(means: 36.6 versus 51.0, p<0.001) and SF-36 PCS 
(means: 32.2 versus 36.7, p<0.001) were significantly 
poorer in the IR group than in the A- group. 
Controlling for these baseline differences by 
multivariate regression modeling did not reduce the 
multivariate SMDs by large amounts when compared 
to the bivariate, for instance, SMDs of SF-36 vitality: 
0.54 versus 0.28. The overall fit of the models in 
predicting the effect differences with the confounders 
ranged from 18.5% (FACT social) to 52.5% (SF-36 
social functioning). The most important confounder 
was the baseline score of the dependent variables 
(p<0.001 for all scales). Age was a significant 
confounder for the SF-36 physical functioning 
(p=0.023). Female genital organ cancer was a 
confounder for the SF-36 social functioning (p=0.024) 
and SF-36 MCS (p=0.007).  
Discussion 
To our best knowledge, this is the first study 
using a naturalistic, longitudinal, comparative cohort 
design on the effectiveness of inpatient cancer 
rehabilitation including control groups in 
Switzerland. Moderate, statistically significant effect 
sizes reflecting improvements in favor of inpatient 
rehabilitation were observed in important health 
dimensions.  
Over the observation period, patients referred to 
inpatient rehabilitation showed significant 
improvements in physical and psychosocial health, 
HRQoL, fatigue, anxiety, and depression, attaining 
small to moderate size effects. In particular, the effects 
of the IR to A+ comparison were higher and less 
affected by baseline differences in the scales than 
those of the IR to A- comparison. In contrast, 
compared to those patients who did not receive 
advice for rehabilitation, the effects were considerably 
smaller and nearly disappeared when controlled for 
confounders (multivariate SMDs close to zero).  
Our findings are consistent with previous 
research showing an improvement of health and 
HRQoL after inpatient rehabilitation [14–16,35]. 
However, most previous studies compared inpatient 
rehabilitation with a specific additional intervention 
or design [36,37]. Similarly to our study, Weis et al. 
had a control group of patients who did not use 
inpatient rehabilitation [20]. In contrast to their study, 
our main control group (A+) and intervention group 
(IR) had comparable scores at baseline. They found 
improvements in both groups but higher effect sizes 
in the rehabilitation group. The largest effects were 
observed in fatigue for both groups, with an effect size 
of d=0.50. Both of Weis et al.’s groups differed mainly 
in psychological well-being [20], while in our study 
differences were also observed in psychological and 
physical health, especially in vitality and fatigue. 
Similar to van Weert et al. [38], we also found that 
fatigue decreased at T1 for all patients, but especially 
for patients with inpatient rehabilitation, with 
moderate effect sizes. In line with Mehnert et al., no 
improvements were observed for patients in the A+ 
group [13]. In addition, patients in the A+ group even 
reported a decrease in social functioning and general 
health. We considered the baseline condition of 
patients in the IR and those in the A+ group to be 
comparable, as both received medical advice from the 
hospital’s physician. As expected, they had similar 
medical characteristics and conditions at baseline. 
Analyses showed that they only differed in age, 
insurance type, and employment status only in trend. 
Data from Switzerland indicate that patients with 
semi-private or private supplementary health 
insurance are more likely to use inpatient 
rehabilitation [8,39,40]. This might be explained by the 
higher chance of obtaining rehabilitation more 
promptly. Patients in the A- group were commonly 
less impaired and consequently more often employed. 
Differences in cancer site should be considered 
in relation to referral. Patients with cancer of digestive 
organs, head and neck, and hematological 
malignancies were more likely to receive referrals 
during hospital stay, probably due to more severe 
interventions and, consequently, more impaired 
participation. Thus, in this subgroup, patients are also 
more likely to have to wait for rehabilitation or to not 
receive reimbursement, and thus not receive inpatient 
rehabilitation at all. In our study, women with breast 
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or female genital organ cancers might not have met 
criteria for referral, as these conditions involve fewer 
impairments, or their need was not identified. Today, 
referrals to inpatient rehabilitation for cancer patients 
are still not based on structured standardized 
procedures in Switzerland. The implementation of 
such screening, therefore, is needed to address 
patients’ needs and to render the potential for 
rehabilitation more reliable [41].  
A strength of our study is the longitudinal, 
naturalistic, cohort design including two different 
healthcare settings (acute hospital and after acute 
treatment) and three comparison groups (inpatient 
rehabilitation and outpatient care with and without 
advice for rehabilitation). Few studies have combined 
assessment of acute care and rehabilitation, largely 
because the transfer of patients to another system 
increases problems in data collection. In addition, our 
baseline conditions were comparable between IR and 
A+ in terms of clinical and socio-demographic 
characteristics. The naturalistic design, used instead 
of randomization, might lead to heterogenic baseline 
in some characteristics and scales. However, baseline 
differences between the groups were controlled by 
multivariate linear regression analyses. This analysis 
provides results that are controlled for some of the 
possible confounders, which approximates equal 
distribution of them by randomization. Thus, the data 
converge to those of randomized controlled trials, the 
gold standard by which to quantify effects [42]. A 
further strength of our study is that the assessments 
were standardized, comprehensive, and 
condition-specific. Finally, the sample sizes of the IR 
and A- groups were large and the proportion of 
completed questionnaires was high.  
This study has some limitations, which should 
be considered. The broad inclusion criteria increased 
the external validity of our results, but such an 
approach limits the interpretation for specific 
diagnoses and patient groups. The small sample size 
of our main control group (A+) represents a further 
limitation of this study. Finally, the high rates of 
dropouts might lead to bias. A particularly high 
number of dropouts occurred in the IR, mainly related 
to transfer to hospital and severe decrease of health 
status.  
Conclusion 
These findings support recommendations for 
inpatient cancer rehabilitation as an effective 
management after initial acute treatment for those 
patients whose health is too severely affected for 
discharge directly at home. Structured standardized 
assessments might be required for the identification of 
patients’ needs and the potential for rehabilitation, 
and such assessments should be implemented on a 
regular basis. 
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